BofA Securities
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 2
- Oracle begins $20B stock and bond sales for AI data centers
Oracle began marketing $10 billion of investment-grade bonds alongside a separate $10 billion common-stock offering, according to a filing with the US Securities and Exchange Commission. The bond sale comprises one floating-rate tranche and five fixed-rate tranches. The preliminary filing did not specify interest rates or allocations among the tranches. Oracle said proceeds may be used for general corporate purposes, including capital expenditure, debt repayment, acquisitions, dividends and share buybacks. The financing is intended to support data-center expansion for AI customers.
The Next Web · 🔥 54 - Nvidia-backed AI drug discovery firm Iambic prices IPO at $16 a share
Iambic Therapeutics announced on Oct. 14 local time that its initial public offering priced at $16 per share for 9.375 million shares, expecting to raise $150 million, with underwriters granted a 30-day option for up to 1.40625 million additional shares, according to 36Kr citing Jiemian. The stock is expected to begin trading on the Nasdaq Global Select Market on Oct. 15 under the ticker "IAM," with the offering expected to close Oct. 16; JPMorgan, Jefferies, BofA Securities and Citigroup are joint book-running managers. Iambic uses AI along with automated chemistry and biology experiments for drug discovery, its candidate IAM1363 has entered clinical trials, and Nvidia previously participated in financing the company.
36氪快讯 · 🔥 0
Experience and discussion from the community
Share my BofA Securities experienceAsk about BofA Securities
Nobody has shared their experience with BofA Securities yet.